Topic Chronic Lymphocytic Leukemia (CLL)
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pirtobrutinib Shows Promise for Chronic Lymphocytic Leukemia
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0923Published: September 2023Expires: 9/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Potential of Fixed-Duration Ibrutinib + Venetoclax in High-Risk Cll
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0823Published: August 2023Expires: 6/5/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, OncologyTopics: Cancer , Chronic Lymphocytic Leukemia (CLL)